نبذة مختصرة : Since their introduction over a decade ago, erythropoiesis-stimulating proteins (ESPs) have become widely used for the treatment of anemia associated with chronic kidney disease (CKD) and chemotherapy-induced anemia (CIA). As a result of this increased utilization, this class of drugs, which
No Comments.